Literature DB >> 15355563

Targeted expression of SHH affects chondrocyte differentiation, growth plate organization, and Sox9 expression.

Sara Tavella1, Roberta Biticchi, Anna Schito, Eleonora Minina, Davide Di Martino, Aldo Pagano, Andrea Vortkamp, William A Horton, Ranieri Cancedda, Silvio Garofalo.   

Abstract

UNLABELLED: The role of Hedgehogs (Hh) in murine skeletal development was studied by overexpressing human Sonic Hedgehog (SHH) in chondrocytes of transgenic mice using the collagen II promoter/enhancer. Overexpression caused a lethal craniorachischisis with major alterations in long bones because of defects in chondrocyte differentiation.
INTRODUCTION: Hedgehogs (Hhs) are a family of secreted polypeptides that play important roles in vertebrate development, controlling many critical steps of cell differentiation and patterning. Skeletal development is affected in many different ways by Hhs. Genetic defects and anomalies of Hhs signaling pathways cause severe abnormalities in the appendicular, axial, and cranial skeleton in man and other vertebrates.
MATERIALS AND METHODS: Genetic manipulation of mouse embryos was used to study in vivo the function of SHH in skeletal development. By DNA microinjection into pronuclei of fertilized oocytes, we have generated transgenic mice that express SHH specifically in chondrocytes using the cartilage-specific collagen II promoter/enhancer. Transgenic skeletal development was studied at different embryonic stages by histology. The expression pattern of specific chondrocyte molecules was studied by immunohistochemistry and in situ hybridization.
RESULTS: Transgenic mice died at birth with severe craniorachischisis and other skeletal defects in ribs, sternum, and long bones. Detailed analysis of long bones showed that chondrocyte differentiation was blocked at prehypertrophic stages, hindering endochondral ossification and trabecular bone formation, with specific defects in different limb segments. The growth plate was highly disorganized in the tibia and was completely absent in the femur and humerus, leading to skeletal elements entirely made of cartilage surrounded by a thin layer of bone. In this cartilage, chondrocytes maintained a columnar organization that was perpendicular to the bone longitudinal axis and directed toward its outer surface. The expression of SHH receptor, Patched-1 (Ptc1), was greatly increased in all cartilage, as well as the expression of parathyroid hormone-related protein (PTHrP) at the articular surface; while the expression of Indian Hedgehog (Ihh), another member of Hh family that controls the rate of chondrocyte maturation, was greatly reduced and restricted to the displaced chondrocyte columns. Transgenic mice also revealed the ability of SHH to upregulate the expression of Sox9, a major transcription factor implicated in chondrocyte-specific gene expression, in vivo and in vitro, acting through the proximal 6.8-kb-long Sox9 promoter.
CONCLUSION: Transgenic mice show that continuous expression of SHH in chondrocytes interferes with cell differentiation and growth plate organization and induces high levels and diffuse expression of Sox9 in cartilaginous bones.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355563     DOI: 10.1359/JBMR.040706

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  37 in total

1.  E-selectin ligand-1 regulates growth plate homeostasis in mice by inhibiting the intracellular processing and secretion of mature TGF-beta.

Authors:  Tao Yang; Roberto Mendoza-Londono; Huifang Lu; Jianning Tao; Kaiyi Li; Bettina Keller; Ming Ming Jiang; Rina Shah; Yuqing Chen; Terry K Bertin; Feyza Engin; Branka Dabovic; Daniel B Rifkin; John Hicks; Milan Jamrich; Arthur L Beaudet; Brendan Lee
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

Review 2.  A Second Career for Chondrocytes-Transformation into Osteoblasts.

Authors:  Lena Ingeborg Wolff; Christine Hartmann
Journal:  Curr Osteoporos Rep       Date:  2019-06       Impact factor: 5.096

3.  SOX9 inhibits β-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties.

Authors:  Wentao Deng; Daniel B Vanderbilt; Chen-Chung Lin; Karen H Martin; Kathleen M Brundage; J Michael Ruppert
Journal:  J Cell Sci       Date:  2015-01-27       Impact factor: 5.285

Review 4.  Mechanisms of synovial joint and articular cartilage development.

Authors:  Ryota Chijimatsu; Taku Saito
Journal:  Cell Mol Life Sci       Date:  2019-06-14       Impact factor: 9.261

5.  Inactivation of Patched1 in the mouse limb has novel inhibitory effects on the chondrogenic program.

Authors:  Stephen J Bruce; Natalie C Butterfield; Vicki Metzis; Liam Town; Edwina McGlinn; Carol Wicking
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

6.  Development of the mammalian axial skeleton requires signaling through the Gα(i) subfamily of heterotrimeric G proteins.

Authors:  Nicholas W Plummer; Karsten Spicher; Jason Malphurs; Haruhiko Akiyama; Joel Abramowitz; Bernd Nürnberg; Lutz Birnbaumer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-11       Impact factor: 11.205

Review 7.  The primary cilium as a signaling nexus for growth plate function and subsequent skeletal development.

Authors:  Emily R Moore; Christopher R Jacobs
Journal:  J Orthop Res       Date:  2017-10-09       Impact factor: 3.494

8.  Regulation of the human SOX9 promoter by Sp1 and CREB.

Authors:  Sonsoles Piera-Velazquez; David F Hawkins; Mary Kate Whitecavage; David C Colter; David G Stokes; Sergio A Jimenez
Journal:  Exp Cell Res       Date:  2007-01-08       Impact factor: 3.905

9.  Zebrafish con/disp1 reveals multiple spatiotemporal requirements for Hedgehog-signaling in craniofacial development.

Authors:  Tyler Schwend; Sara C Ahlgren
Journal:  BMC Dev Biol       Date:  2009-11-30       Impact factor: 1.978

10.  delta-EF1 is a negative regulator of Ihh in the developing growth plate.

Authors:  Ellen Bellon; Frank P Luyten; Przemko Tylzanowski
Journal:  J Cell Biol       Date:  2009-11-23       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.